CINCINNATI--(BUSINESS WIRE)--Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ: VIVO) today announced that it has made a minority investment in Oasis Diagnostics® Corporation (“Oasis”), with the right to acquire Oasis in the future. The terms of the transaction were not disclosed.
Oasis designs, develops, manufactures and sells pre-analytic tools for the collection, preservation, and transportation of saliva/oral fluids. Oasis’ focus is to provide high-quality, innovative diagnostic solutions based on non-invasive saliva-based technologies.
Help employers find you! Check out all the jobs and post your resume.
